Jinfeng Single Cell won the first prize of the 11th Chongqing “Five Small” Innovation Award

Release time:2026/9/15


 List of first prize winners (56)
Recently, the final results of the 11th Chongqing “Five Small” Innovation Showcase and Excellent Project Promotion and Exhibition Exchange Series were officially announced. Chongqing Jinfeng Jixiang Single Cell Biotechnology Co., Ltd. (hereinafter referred to as "Jinfeng Single Cell"), a company incubated by Jinfeng Laboratory, stood out with its cutting-edge scientific research results and won the first prize in this competition. This is another important achievement of Jinfeng Laboratory in promoting the deep integration of scientific and technological innovation and industrial innovation.

      This event is jointly sponsored by 13 municipal departments including the Municipal Youth League Committee, Municipal Education Commission, and Municipal Science and Technology Bureau. It is a highly influential youth innovation, entrepreneurship and technological innovation brand competition in our city. The event went through multiple rounds of rigorous competitions including preliminary selection and municipal road show defense. Jinfeng Single Cell's entry project broke through hundreds of results in the city and was highly recognized by the judges for its solid technological innovation, clear application scenarios and considerable transformation value.

Refractory tumor cells such as glioblastoma are highly heterogeneous and have complex microenvironments, making it extremely difficult to discover precise targets, which is a core problem in the field of precise tumor diagnosis and treatment. Relying on Jinfeng Laboratory's cutting-edge scientific research platform and resource advantages, the company has built a precise target discovery platform for glioma based on single cells and spatial multi-omics, effectively solving industry pain points. The platform integrates the core technologies of single-cell omics, spatial multi-omics, and full-length transcriptome to form a complete technical closed loop of "discovery-positioning-analysis-verification-decision-making", which can accurately analyze tumor heterogeneity, complete spatial pathological localization, mine key molecular targets, and screen high-quality clinical targets through multi-level experimental verification to achieve efficient transformation of multi-omics data into candidate targets, providing a new technical paradigm for precision tumor research.

      This award is a full affirmation of Jinfeng Laboratory’s scientific research incubation and achievement transformation capabilities. As an important part of Chongqing's strategic scientific and technological strength, the laboratory actively integrates into the city's "203060" key breakthrough system, and continues to enhance the "total platform" and "total chain length" functions of life and health science and technology innovation. In the next step, the laboratory will better play the role of Chongqing Laboratory's strategic leading innovation platform, anchor the research direction of "next generation diagnosis of major diseases", and contribute to Chongqing's high-level construction of an innovative and strong city with the actual results of the deep integration of scientific and technological innovation and industrial innovation.